MICHAEL BREGENZER: Open Payments
NPI 1326560871 · LONGMONT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 3 payments from 3 companies in 2025. Trend: 2023 $303 · 2024 $373 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 1 | $139 |
| Novo Nordisk Inc | 1 | $99 |
| Amgen Inc. | 1 | $51 |
Products named: TARPEYO, Ozempic, TAVNEOS.
Industry payments across CO — which companies pay providers there.
